Key result
LIM Mineralization Protein-1 inhibits malignant phenotypes in human osteosarcoma cells.
Supports LMP-1 targeting in osteosarcoma; extends preclinical evidence of phenotype inhibition but should not yet change practice.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question. LIM Mineralization Protein-1 inhibits the malignant phenotypes of human osteosarcoma cells.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: